Keck School Faculty

Julie Culver

Julie Culver

Instructor of Clinical Medicine
Medicine
USC Norris Comprehensive Cancer Center Health Sciences Campus Los Angeles

Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells Gynecol Oncol. 2020 Oct 05. . View in PubMed

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families J Clin Oncol. 2020 Mar 01; 38(7):674-685. . View in PubMed

Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D J Natl Cancer Inst. 2020 Feb 28. . View in PubMed

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices NPJ Genom Med. 2018; 3:7. . View in PubMed

Patient communication of cancer genetic test results in a diverse population Transl Behav Med. 2018 01 29; 8(1):85-94. . View in PubMed

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort Cancer Genet. 2016 Apr; 209(4):130-7. . View in PubMed

A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer Cancer Genet. 2016 Mar; 209(3):75-81. . View in PubMed

Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs J Cancer Educ. 2012 Jun; 27(3):467-77. . View in PubMed

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors J Genet Couns. 2012 Apr; 21(2):151-61. . View in PubMed

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce Genet Med. 2011 Sep; 13(9):832-40. . View in PubMed

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine CA Cancer J Clin. 2011 Sep-Oct; 61(5):327-59. . View in PubMed

Development and evaluation of a decision aid for BRCA carriers with breast cancer J Genet Couns. 2011 Jun; 20(3):294-307. . View in PubMed

Limited family structure and BRCA gene mutation status in single cases of breast cancer JAMA. 2007 Jun 20; 297(23):2587-95. . View in PubMed

Assessing breast cancer risk and BRCA1/2 carrier probability Breast Dis. 2006-2007; 27:5-20. . View in PubMed

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors J Genet Couns. 2004 Apr; 13(2):83-114. . View in PubMed

Powered by SC CTSI
Go to Top